Survivor care for pediatric cancer survivors: A continuously evolving discipline

Current Opinion in Oncology

Volumn 27, Issue 4, 2015, Pages 291-296

  Record, Elizabeth O ^a   Meacham, Lillian R ^a,b  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Late effects; Pediatric cancer; Survivor care

Indexed keywords

ANTHRACYCLINE;

CANCER THERAPY; CARDIOVASCULAR DISEASE; CHILDHOOD CANCER SURVIVOR; HEALTH STATUS; HUMAN; LUNG DISEASE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SECOND CANCER; SELF CARE; ADULT; AGE; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; CHILD; MIDDLE AGED; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; RISK FACTOR; SURVIVOR; YOUNG ADULT;

ADULT; AGE FACTORS; ANTHRACYCLINES; CARDIOVASCULAR DISEASES; CHILD; HUMANS; MIDDLE AGED; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SURVIVORS; YOUNG ADULT;

EID: 84952649703     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0000000000000195     Document Type: Review

References (50)

1. Armenian SH, Robison LL. Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects. Curr Opin Pediatr 2013; 25:16-22.
2. Hochberg JC, Cairo MS, Friedman DM. Cardio-oncology issues among pediatric cancer and stem cell transplant survivors. Cardiol Rev 2014; 22:268-274.
3. Wallace WH. Oncofertility and preservation of reproductive capacity in children and young adults. Cancer 2011; 117 (Suppl 10):2301-2310.
4. Waimey KE, Duncan FE, Su HI, et al. Future directions in oncofertility and fertility preservation: a report from the 2011 Oncofertility Consortium Conference. J Adolesc Young Adult Oncol 2013; 2:25-30.
5. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355:1572-1582.
6. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. J Am Med Assoc 2013; 309:2371-2381.
7. Henderson TO, Ness KK, Cohen HJ. Accelerated aging among cancer survivors: from pediatrics to geriatrics. Am Soc Clin Oncol Educ Book 2014; e423-e430.
8. Armstrong GT, Kavashima T, Leisenring W, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 2014; 32:1218-1227.
9. Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med 1992; 8:1-17.
10. Ness KK, Armstrong GT, Kundu M, et al. Frailty in childhood cancer survivors. Cancer 2014. [Epub ahead of print]
11. Ness KK, Hudson MM, Ginsberg JP, et al. Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009; 27:2382-2389.
12. From cancer patient to cancer survivor: lost in transition; 2006. Institute of Medicine: Washington, DC.
13. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers; 2008; Version 3.0. http://www.survivorshipguidelines. org/pdf/LTFUGuidelines.pdf. [Accessed 9 April 2015]
14. Kremer LC, Mulder RL, Oeffinger KC, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer 2013; 60:543-549.
15. Skinner R, Oeffinger KC. Developing international consensus for late effects screening and guidance. Curr Opin Support Palliat Care 2013; 7:303-308.
16. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27:2328-2338.
17. Lipshultz SE, Diamond MB, Franco VI, et al. Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers. Paediatr Drugs 2014; 16:373-389.
18. Armenian SH, Gelehrter SK, Vase T, et al. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors. Clin Cancer Res 2014; 20:6314-6323.
19. Hensley ML, Hagerty KL, Kewalramani T, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 2009; 27:127-145.
20. Kalam K, Marwick TH. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-Analysis. Eur J Cancer 2013; 49:2900-2909.
21. Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol 2013; 31:3673-3680.
22. Chow EJ, Chen Y, Kremer LC, et al. Individual prediction of heart failure among childhood cancer survivors. J Clin Oncol 2015; 33:394-402.
23. Dillenburg RF, Nathan P, Mertens L. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician. Eur J Pediatr 2013; 172:1149-1160.
24. Landier W, Armenian SH, Lee J, et al. Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. J Clin Oncol 2012; 30:4401-4408.
25. Ito K, Mercado N. STOP accelerating lung aging for the treatment of COPD. Exp Gerontol 2014; 59:21-27.
26. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2008; 100:1368-1379.
27. Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010; 102:1083-1095.
28. Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. J Am Med Assoc 2011; 305:2311-2319.
29. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: lifelong risks and responsibilities. Nat Rev Cancer 2014; 14:61-70.
30. Moskowitz CS, Chou JF, Wolden SL, et al. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol 2014; 32:2217-2223.
31. Low-dose tamoxifen citrate in reducing breast cancer risk in radiation-induced cancer survivors. 2015. http://www.cancer.gov/clinicaltrials/search/view?-cdrid=687084&version=HealthProfessional&protocolsearchid=13716287. [Accessed 9 April 2015]
32. Oeffinger KC, Baxi SS, Novetsky Friedman D, et al. Solid tumor second primary neoplasms: who is at risk, what can we do? Semin Oncol 2013; 40:676-689.
33. Kovalchik SA, Ronkers CM, Veiga LH, et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol 2013; 31:119-127.
34. Morton LM, Onel K, Curtis RE, et al. The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. Am Soc Clin Oncol Educ Book 2014; e57-e67.
35. Nathan PC, Ford JS, Henderson TO, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study Cohort. J Clin Oncol 2009; 27:2363-2373.
36. Davies NJ, Batehup L. Towards a personalised approach to aftercare: a review of cancer follow-up in the UK. J Cancer Surviv 2011; 5:142-151.
37. Shad A, Myers SN, Hennessy K. Late effects in cancer survivors: "the shared care model". Curr Oncol Rep 2012; 14:182-190.
38. Edgar AB, Duffin K, Borthwick S, et al. Can intensity of long-term follow-up for survivors of childhood and teenage cancer be determined by therapy-based risk stratification? BMJ Open 2013; 3:e002451.
39. Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol 2006; 24:5117-5124.
40. Nathan PC, Schiffman JD, Huang S, et al. Childhood cancer survivorship educational resources in North American pediatric hematology/oncology fellowship training programs: a survey study. Pediatr Blood Cancer 2011; 57:1186-1190.
41. Greenfield D, Hjorth L. Late effects care as an emerging clinical specialty in paediatric oncology: how to prepare the workforce? Curr Opin Support Palliat Care 2013; 7:296-302.
42. Barakat LP, Schwartz LA, Szabo MM, et al. Factors that contribute to posttreatment follow-up care for survivors of childhood cancer. J Cancer Surviv 2012; 6:155-162.
43. McCabe MS, Partridge AH, Grunfeld E, et al. Risk-based healthcare, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol 2013; 40:804-812.
44. Hex N, Bartlett C. Cost-effectiveness of follow-up services for childhood cancer survivors outside the cancer setting. Curr Opin Support Palliat Care 2013; 7:314-317.
45. McCarthy MC, Campo M, Drew SE. Pediatric oncology survivorship: conveying risks and communicating information at the right time for the individual. Curr Opin Support Palliat Care 2013; 7:289-295.
46. Cherven B, Mertens A, Meacham LR, et al. Knowledge and risk perception of late effects among childhood cancer survivors and parents before and after visiting a childhood cancer survivor clinic. J Pediatr Oncol Nurs 2014; 31:339-349.
47. Cherven BO, Meacham LR. Information needs of childhood cancer survivors: a case for survivor clinic. Pediatr Blood Cancer 2014; 61:189-190.
48. Ford JS, Chou JF, Sklar CA. Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment. J Cancer Surviv 2013; 7:535-543.
49. Poplack DG, Fordis M, Landier W, et al. Childhood cancer survivor care: development of the Passport for Care. Nat Rev Clin Oncol 2014; 11:740-750.
50. Williamson R, Meacham L, Cherven B, et al. Predictors of successful use of a web-based healthcare document storage and sharing system for pediatric cancer survivors: Cancer SurvivorLink. J Cancer Surviv 2014; 8:355-363.